 |
|||
 |
 |
 |
|
PSMA ADC Clinical Trial
Progenics Pharmaceuticals, through is subsidiary PSMA Development Company, LLC (PDC), is conducting a phase 1 clinical trial in men who have progressive prostate cancer and who have had no more than two prior chemotherapy regimens, one of which must contain taxane or a taxane derivative. If you think you, a patient of yours, or someone you know, may qualify for this trial, please call 866-644-7188 and leave a name, a contact number and city and state of residence. All information will be kept confidential. A representative will return your call and provide additional information.